Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches.

Niarakis A, Ostaszewski M, Mazein A, Kuperstein I, Kutmon M, Gillespie ME, Funahashi A, Acencio ML, Hemedan A, Aichem M, Klein K, Czauderna T, Burtscher F, Yamada TG, Hiki Y, Hiroi NF, Hu F, Pham N, Ehrhart F, Willighagen EL, Valdeolivas A, Dugourd A, Messina F, Esteban-Medina M, Peña-Chilet M, Rian K, Soliman S, Aghamiri SS, Puniya BL, Naldi A, Helikar T, Singh V, Fernández MF, Bermudez V, Tsirvouli E, Montagud A, Noël V, Ponce-de-Leon M, Maier D, Bauch A, Gyori BM, Bachman JA, Luna A, Piñero J, Furlong LI, Balaur I, Rougny A, Jarosz Y, Overall RW, Phair R, Perfetto L, Matthews L, Rex DAB, Orlic-Milacic M, Gomez LCM, De Meulder B, Ravel JM, Jassal B, Satagopam V, Wu G, Golebiewski M, Gawron P, Calzone L, Beckmann JS, Evelo CT, D'Eustachio P, Schreiber F, Saez-Rodriguez J, Dopazo J, Kuiper M, Valencia A, Wolkenhauer O, Kitano H, Barillot E, Auffray C, Balling R, Schneider R, COVID-19 Disease Map Community

Open source

DOI: 10.3389/fimmu.2023.1282859
Published: 2023
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1282859,
  title = {Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches.},
  author = {Niarakis A and Ostaszewski M and Mazein A and Kuperstein I and Kutmon M and Gillespie ME and Funahashi A and Acencio ML and Hemedan A and Aichem M and Klein K and Czauderna T and Burtscher F and Yamada TG and Hiki Y and Hiroi NF and Hu F and Pham N and Ehrhart F and Willighagen EL and Valdeolivas A and Dugourd A and Messina F and Esteban-Medina M and Peña-Chilet M and Rian K and Soliman S and Aghamiri SS and Puniya BL and Naldi A and Helikar T and Singh V and Fernández MF and Bermudez V and Tsirvouli E and Montagud A and Noël V and Ponce-de-Leon M and Maier D and Bauch A and Gyori BM and Bachman JA and Luna A and Piñero J and Furlong LI and Balaur I and Rougny A and Jarosz Y and Overall RW and Phair R and Perfetto L and Matthews L and Rex DAB and Orlic-Milacic M and Gomez LCM and De Meulder B and Ravel JM and Jassal B and Satagopam V and Wu G and Golebiewski M and Gawron P and Calzone L and Beckmann JS and Evelo CT and D'Eustachio P and Schreiber F and Saez-Rodriguez J and Dopazo J and Kuiper M and Valencia A and Wolkenhauer O and Kitano H and Barillot E and Auffray C and Balling R and Schneider R and COVID-19 Disease Map Community},
  year = {2023},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2023.1282859},
  url = {https://doi.org/10.3389/fimmu.2023.1282859}
}

RIS

TY  - JOUR
TI  - Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches.
AU  - Niarakis A
AU  - Ostaszewski M
AU  - Mazein A
AU  - Kuperstein I
AU  - Kutmon M
AU  - Gillespie ME
AU  - Funahashi A
AU  - Acencio ML
AU  - Hemedan A
AU  - Aichem M
AU  - Klein K
AU  - Czauderna T
AU  - Burtscher F
AU  - Yamada TG
AU  - Hiki Y
AU  - Hiroi NF
AU  - Hu F
AU  - Pham N
AU  - Ehrhart F
AU  - Willighagen EL
AU  - Valdeolivas A
AU  - Dugourd A
AU  - Messina F
AU  - Esteban-Medina M
AU  - Peña-Chilet M
AU  - Rian K
AU  - Soliman S
AU  - Aghamiri SS
AU  - Puniya BL
AU  - Naldi A
AU  - Helikar T
AU  - Singh V
AU  - Fernández MF
AU  - Bermudez V
AU  - Tsirvouli E
AU  - Montagud A
AU  - Noël V
AU  - Ponce-de-Leon M
AU  - Maier D
AU  - Bauch A
AU  - Gyori BM
AU  - Bachman JA
AU  - Luna A
AU  - Piñero J
AU  - Furlong LI
AU  - Balaur I
AU  - Rougny A
AU  - Jarosz Y
AU  - Overall RW
AU  - Phair R
AU  - Perfetto L
AU  - Matthews L
AU  - Rex DAB
AU  - Orlic-Milacic M
AU  - Gomez LCM
AU  - De Meulder B
AU  - Ravel JM
AU  - Jassal B
AU  - Satagopam V
AU  - Wu G
AU  - Golebiewski M
AU  - Gawron P
AU  - Calzone L
AU  - Beckmann JS
AU  - Evelo CT
AU  - D'Eustachio P
AU  - Schreiber F
AU  - Saez-Rodriguez J
AU  - Dopazo J
AU  - Kuiper M
AU  - Valencia A
AU  - Wolkenhauer O
AU  - Kitano H
AU  - Barillot E
AU  - Auffray C
AU  - Balling R
AU  - Schneider R
AU  - COVID-19 Disease Map Community
PY  - 2023
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2023.1282859
UR  - https://doi.org/10.3389/fimmu.2023.1282859
ER  -

APA

A, N., M, O., A, M., I, K., M, K., ME, G., A, F., ML, A., A, H., M, A., K, K., T, C., F, B., TG, Y., Y, H., NF, H., F, H., N, P., F, E., EL, W., A, V., A, D., F, M., M, E., M, P., K, R., S, S., SS, A., BL, P., A, N., T, H., V, S., MF, F., V, B., E, T., A, M., V, N., M, P., D, M., A, B., BM, G., JA, B., A, L., J, P., LI, F., I, B., A, R., Y, J., RW, O., R, P., L, P., L, M., DAB, R., M, O., LCM, G., B, D. M., JM, R., B, J., V, S., G, W., M, G., P, G., L, C., JS, B., CT, E., P, D., F, S., J, S., J, D., M, K., A, V., O, W., H, K., E, B., C, A., R, B., R, S., & Community, C. D. M. (2023). Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2023.1282859

Source records

pubmed · retrieved 2026-09-25T10:28:49.747Z